Rights issue 2023

Gradientech’s Board of Directors have decided to carry out a new issue of shares with preferential rights for existing shareholders of approximately SEK 25.8 million. The purpose of the rights issue is to strengthen the company’s financial position to enable investments primarily in sales and marketing, production of market-approved instruments and tests, preparing and starting clinical studies in the US, and production scale-up.

Information folder

Here you will find all the information about the rights issue.

Read the information folder

Complete terms and conditions


Investor presentation

Gradientech arranged an investor meeting in Stockholm on 27 November. In addition to company information and details about the rights issue, our Italian distributor a.d.a. and Stefan Willemsen, who is our strategic advisor in the US, shared their views on the respective markets and the potential for QuickMIC. You can watch the presentation on demand here.

To the presentation


20 November 2023
Record Day in the rights issue

22 November – 6 December 2023
Subscription period

27 November 2023
Investor presentation in Stockholm (see details above)

8 December 2023
Estimated date for publication of the outcome of the rights issue

Subscribe for shares with subscription rights

Directly registered shareholders

  • As from 22 November 2023 you can log in to Nordic Issuing and fill in the number of rights you wish to use, number of shares and amount as well as VP account number. Register and pay according to the payment instructions you receive.
  • Registration and payment must be registered with Nordic Issuing no later than 6 December 2023.

To Nordic Issuing

Nominee registered shareholders

  • Subscription and payment of new shares with the support of preferential rights takes place via your bank or other nominee. Often, the bank/nominee sends you a digital message as the account holder. But it is enough to log into your securities account from the first day of the subscription period to receive instructions on how to use your preferential rights.
  • Please note that banks/nominee can set different time limits for the last day for subscription, so be there in good time.

Subscribe for more shares/subscribe for shares without subscription rights

Regardless of whether you do not previously own shares or if your shares are directly or nominee registered, you can always subscribe for more shares directly via Nordic Issuing’s platform:

To Nordic Issuing

Note: If you already have shares in Gradientech that are registered in the name of a nominee, it is recommended that subscription of shares without subscription rights is made via your bank/nominee in connection with the exercise of your subscription rights.


For questions on how to subscribe for the rights issue, please contact:

Nordic Issuing
Tel: +46 40 632 00 20

For other questions about Gradientech, please contact:

Urban Adolfsson
CFO Gradientech

Ann Charlotte Svensson
Investor Relations Gradientech

Gradientech is an ISO13485 certified company since 2017


Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala


About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2024 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book